SPDR S&P Pharmaceuticals ETF – AMEX:XPH

Add to watchlist

$45.94

+2.44

+5.63%

Market closed

Open in about 1 hour

+4.42%

month

+4.42%

quarter

+3.75%

year

Market Cap	236.26M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	N/A

Revenue	N/A
EBITDA	N/A
Income	N/A
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

SPDR S&P Pharmaceuticals ETF
Latest News

Wednesday, 14 August 2024
12:51	Pharma ETFs in Focus Post Solid Q2 Earnings	zacks.com
Wednesday, 24 July 2024
07:21	Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?	zacks.com
Wednesday, 17 July 2024
07:20	Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?	zacks.com
Friday, 31 May 2024
11:02	Finding Opportunity in Unloved Healthcare ETFs	etftrends.com
Thursday, 16 May 2024
07:20	Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?	zacks.com
Tuesday, 14 May 2024
09:01	5 Beaten-Down Top-Ranked ETFs to Buy for a Turnaround	Zacks Investment Research
Tuesday, 7 May 2024
12:31	A Look at Pharma ETFs Post Q1 Earnings	Zacks Investment Research
Thursday, 15 February 2024
07:21	Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?	Zacks Investment Research
Wednesday, 14 February 2024
07:21	Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?	Zacks Investment Research
Monday, 12 February 2024
14:01	A Look at Pharma ETFs After Q4 Earnings	Zacks Investment Research
Friday, 15 December 2023
07:31	Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?	Zacks Investment Research
Thursday, 14 December 2023
07:31	Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?	Zacks Investment Research
Wednesday, 8 November 2023
12:46	Pharma ETFs in Focus Post Q3 Earnings	Zacks Investment Research
Monday, 18 September 2023
07:32	Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?	Zacks Investment Research
Monday, 21 August 2023
07:31	Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?	Zacks Investment Research
Friday, 11 August 2023
13:47	Pharma ETFs in Focus Post Q2 Earnings	Zacks Investment Research
Wednesday, 9 August 2023
14:27	Cautious on Big Tech & AI? Try These Value-Focused Sector ETFs	Zacks Investment Research
Tuesday, 18 July 2023
07:34	Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?	Zacks Investment Research
Sunday, 16 July 2023
10:24	XPH: Non-Diversified U.S.-Based Large-Cap Pharma ETF Isn't Very Attractive	Seeking Alpha
Wednesday, 21 June 2023
08:03	Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?	Zacks Investment Research
Thursday, 18 May 2023
07:40	Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?	Zacks Investment Research
Tuesday, 9 May 2023
13:01	Pharma ETFs Gain Post Q1 Earnings	Zacks Investment Research
Friday, 21 April 2023
07:39	Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?	Zacks Investment Research
Tuesday, 4 April 2023
23:52	XPH: Revenue Challenges Ahead For U.S. Pharmaceuticals	Seeking Alpha
Wednesday, 15 March 2023
07:41	Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?	Zacks Investment Research
Friday, 13 January 2023
07:32	Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?	Zacks Investment Research
Thursday, 12 January 2023
07:32	Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?	Zacks Investment Research
Wednesday, 11 January 2023
18:09	Can Health Care Stocks Outperform Again In 2023?	Seeking Alpha
Tuesday, 13 December 2022
12:48	Amgen to Buy Horizon Therapeutics: ETFs to Bet On	Zacks Investment Research
Sunday, 13 November 2022
03:33	XPH: U.S. Pharmaceuticals Stocks Are Probably Fairly Valued, Cyclically Unattractive	Seeking Alpha

Ideas & Opinions

Seeking Alpha 7 May 2024

Four Reasons Why Organon Stock Is A Good Buy
Seeking Alpha 4 Feb 2024

Bristol-Myers Squibb: Massive Discount Spells Opportunity
Seeking Alpha 14 Jan 2024

Week In Review: China Biopharmas Book $9B In Deals During JP Morgan Conference Week
Seeking Alpha 12 Jan 2024

Horiba: Wonderful Japanese Company At A Very Attractive Price
Seeking Alpha 7 Jan 2024

Week In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4B
Seeking Alpha 28 Sep 2023

Pfizer: Sell-Off Overdone, Healthy Pipeline To Sustain Above 15% ROE
Seeking Alpha 23 Jul 2023

Week In Review: Novartis In $1 Billion Deal For DTx Pharma
Seeking Alpha 29 May 2023

Pfizer: Not Quite Dead Money Walking
Seeking Alpha 31 Mar 2023

Merck & Co., Inc. Is Getting Healthier
Seeking Alpha 23 Aug 2022

Circling Back On Precigen

Frequently Asked Questions (FAQ)

What's the price of SPDR S&P Pharmaceuticals ETF stock today?

One share of SPDR S&P Pharmaceuticals ETF stock can currently be purchased for approximately $45.94.
When is SPDR S&P Pharmaceuticals ETF's next earnings date?

Unfortunately, SPDR S&P Pharmaceuticals ETF's (XPH) next earnings date is currently unknown.
Does SPDR S&P Pharmaceuticals ETF pay dividends?

Yes, SPDR S&P Pharmaceuticals ETF pays dividends and its trailing 12-month yield is 0.68% with 0% payout ratio. The last SPDR S&P Pharmaceuticals ETF stock dividend of $0.09 was paid on 26 Sep 2025.
How much money does SPDR S&P Pharmaceuticals ETF make?

SPDR S&P Pharmaceuticals ETF has a market capitalization of 236.26M.
What is SPDR S&P Pharmaceuticals ETF's stock symbol?

SPDR S&P Pharmaceuticals ETF is traded on the AMEX under the ticker symbol "XPH".
What is SPDR S&P Pharmaceuticals ETF's primary industry?

Company operates in the Financial Services sector and Asset Management industry.
How do i buy shares of SPDR S&P Pharmaceuticals ETF?

Shares of SPDR S&P Pharmaceuticals ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
When SPDR S&P Pharmaceuticals ETF went public?

SPDR S&P Pharmaceuticals ETF is publicly traded company for more then 19 years since IPO on 22 Jun 2006.
What is SPDR S&P Pharmaceuticals ETF's official website?

The official website for SPDR S&P Pharmaceuticals ETF is ssga.com.

SPDR S&P Pharmaceuticals ETF

ssga.com

Exchange:

AMEX

Full time employees:

Industry:

Asset Management

Sector:

Financial Services

In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").

One Iron Street
Boston, 2210

CIK: 0001064642
ISIN: US78464A7220
CUSIP: 78464A722